FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2401771656> ?p ?o ?g. }

• W2401771656 abstract "Tissue based methods for the detection of ALK fusions include FISH and IHC. Patients with advanced non-small cell lung cancer (NSCLC) may not be good candidates for biopsies and in cases where tissue is obtained, it is not always sufficient for testing. Additionally, determination of the full range of tumor heterogeneity and any impact of molecular variants on therapeutic responses may not be fully captured by the current FISH and IHC tests being conducted for ALK. For these reasons, blood-based testing that uses PCR and NGS methods for detection of mRNA fusion transcripts and somatic variants in circulation are becoming more clinically relevant. Pre-analytic as well as primer design are critical parameters in the development of circulating RNA tests. We have approached the pre-analytic variables by assessing multiple potential sources of fusion RNAs in prospectively-collected plasma samples, including cell-free RNA (cfRNA) and exosomal RNA. Additionally, test development for ALK, RET and ROS1 (ARR) utilized fusion-partner agnostic primers, only requiring knowledge of the fusion kinase sequence. This test technology has previously been shown in FFPE-extracted mRNA specimens to have the unique capability to identify common fusions, including EML4-ALK variants 1 and 3a/b, as well as rare fusions and novel transcript variants. In this study we have extended the capability of this technology to plasma samples from donors previously diagnosed with NSCLC. Data generated during the development of this test involved extraction of RNA from cell lines and donor plasma, processing to cDNA, adaptor ligation and two-step anchored PCR with specificity for human ALK, RET and ROS1. Amplicons were sequenced on a MiSeq (v2 chemistry) and reads were mapped to the human genome and a fusion specific database in order to identify the specific fusion partner(s). Test turn-around time from RNA extraction to results averaged 72 hours. With this test system we evaluated known variant-positive cell lines for EML4-ALK, SLC34A2-ROS1 and CCDC6-RET, as well as remnant prospectively-collected plasma from NSCLC donors (females of less than 65 years of age, and wild-type for circulating EGFR sensitizing and KRAS somatic variants). All cell lines were positive for the respective fusions (lower limit of input RNA at 25ng) and negative in test cross-reactivity experiments (up to 250ng input RNA). The presence of the fusions in the cell lines were independently confirmed with variant-specific qPCR assays. We additionally tested cell-line spiked human donor samples and successfully demonstrated detection of cell-line derived ARR fusions and donor-derived wild-type ALK, RET & ROS1. All human donor samples passed QC measures based on control gene expression. Ongoing experiments are being conducted to further develop this test and evaluate its relevance for routine blood-based clinical laboratory testing using plasma from patients diagnosed with NSCLC. Citation Format: Hestia Mellert, Kristina Koch, Shannon Campbell, Gary Pestano. Rapid blood-based test for ALK, RET and ROS1 mRNA fusions and somatic variants in NSCLC. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2015 Nov 5-9; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2015;14(12 Suppl 2):Abstract nr C148." @default.
• W2401771656 created "2016-06-24" @default.
• W2401771656 creator A5054839814 @default.
• W2401771656 creator A5063854011 @default.
• W2401771656 creator A5075156214 @default.
• W2401771656 creator A5083775854 @default.
• W2401771656 date "2015-12-01" @default.
• W2401771656 modified "2023-09-25" @default.
• W2401771656 title "Abstract C148: Rapid blood-based test for ALK, RET and ROS1 mRNA fusions and somatic variants in NSCLC" @default.
• W2401771656 doi "https://doi.org/10.1158/1535-7163.targ-15-c148" @default.
• W2401771656 hasPublicationYear "2015" @default.
• W2401771656 type Work @default.
• W2401771656 sameAs 2401771656 @default.
• W2401771656 citedByCount "0" @default.
• W2401771656 crossrefType "proceedings-article" @default.
• W2401771656 hasAuthorship W2401771656A5054839814 @default.
• W2401771656 hasAuthorship W2401771656A5063854011 @default.
• W2401771656 hasAuthorship W2401771656A5075156214 @default.
• W2401771656 hasAuthorship W2401771656A5083775854 @default.
• W2401771656 hasConcept C104317684 @default.
• W2401771656 hasConcept C105580179 @default.
• W2401771656 hasConcept C112190416 @default.
• W2401771656 hasConcept C134305767 @default.
• W2401771656 hasConcept C153911025 @default.
• W2401771656 hasConcept C178790620 @default.
• W2401771656 hasConcept C185592680 @default.
• W2401771656 hasConcept C187882448 @default.
• W2401771656 hasConcept C2777563447 @default.
• W2401771656 hasConcept C502942594 @default.
• W2401771656 hasConcept C54355233 @default.
• W2401771656 hasConcept C67705224 @default.
• W2401771656 hasConcept C70721500 @default.
• W2401771656 hasConcept C86803240 @default.
• W2401771656 hasConceptScore W2401771656C104317684 @default.
• W2401771656 hasConceptScore W2401771656C105580179 @default.
• W2401771656 hasConceptScore W2401771656C112190416 @default.
• W2401771656 hasConceptScore W2401771656C134305767 @default.
• W2401771656 hasConceptScore W2401771656C153911025 @default.
• W2401771656 hasConceptScore W2401771656C178790620 @default.
• W2401771656 hasConceptScore W2401771656C185592680 @default.
• W2401771656 hasConceptScore W2401771656C187882448 @default.
• W2401771656 hasConceptScore W2401771656C2777563447 @default.
• W2401771656 hasConceptScore W2401771656C502942594 @default.
• W2401771656 hasConceptScore W2401771656C54355233 @default.
• W2401771656 hasConceptScore W2401771656C67705224 @default.
• W2401771656 hasConceptScore W2401771656C70721500 @default.
• W2401771656 hasConceptScore W2401771656C86803240 @default.
• W2401771656 hasLocation W24017716561 @default.
• W2401771656 hasOpenAccess W2401771656 @default.
• W2401771656 hasPrimaryLocation W24017716561 @default.
• W2401771656 hasRelatedWork W2023751019 @default.
• W2401771656 hasRelatedWork W2040545666 @default.
• W2401771656 hasRelatedWork W2046045072 @default.
• W2401771656 hasRelatedWork W2145120022 @default.
• W2401771656 hasRelatedWork W2155351580 @default.
• W2401771656 hasRelatedWork W2159398951 @default.
• W2401771656 hasRelatedWork W2330903119 @default.
• W2401771656 hasRelatedWork W2562711298 @default.
• W2401771656 hasRelatedWork W2568469824 @default.
• W2401771656 hasRelatedWork W2794472180 @default.
• W2401771656 hasRelatedWork W2802954407 @default.
• W2401771656 hasRelatedWork W2894749921 @default.
• W2401771656 hasRelatedWork W2936168176 @default.
• W2401771656 hasRelatedWork W2948264481 @default.
• W2401771656 hasRelatedWork W3032335838 @default.
• W2401771656 hasRelatedWork W3106826384 @default.
• W2401771656 hasRelatedWork W3114295824 @default.
• W2401771656 hasRelatedWork W3129310897 @default.
• W2401771656 hasRelatedWork W3162102278 @default.
• W2401771656 hasRelatedWork W3162838948 @default.
• W2401771656 isParatext "false" @default.
• W2401771656 isRetracted "false" @default.
• W2401771656 magId "2401771656" @default.
• W2401771656 workType "article" @default.